<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Innogenetics</id>
	<title>Innogenetics - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Innogenetics"/>
	<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Innogenetics&amp;action=history"/>
	<updated>2026-05-15T16:48:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.1</generator>
	<entry>
		<id>http://debianws.lexgopc.com/wiki143/index.php?title=Innogenetics&amp;diff=3735234&amp;oldid=prev</id>
		<title>imported&gt;Silverije at 22:01, 20 June 2023</title>
		<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Innogenetics&amp;diff=3735234&amp;oldid=prev"/>
		<updated>2023-06-20T22:01:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;!-- Deleted image removed: [[Image:InnogeneticsBldg 080116.jpg|thumb|Innogenetics (now Fujirebio Europe) headquarters in [[Zwijnaarde]].]] --&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Innogenetics N.V.&amp;#039;&amp;#039;&amp;#039; (now Fujirebio Europe N.V.) was an international [[in vitro diagnostics]] (IVD) company, with headquarters in [[Ghent]], Belgium. Founded in 1985, the company developed and marketed IVD testing solutions as well as OEM raw materials. The company was acquired in September 2010 by Japanese [[Fujirebio]] Inc., an H.U. Group Holdings, Inc company, and changed name to Fujirebio Europe on October 1, 2013. The current CEO of Fujirebio Europe N.V. is [[Christiaan De Wilde]].&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
Innogenetics was founded on 18 July 1985, by [[Erik Tambuyzer]], [[Hugo Van Heuverswyn]] and [[Rudi Mariën]]. In 1992, the company launched the first commercial tests for [[cystic fibrosis]] in [[Europe]] (INNO-LiPA CFTR) and in 1993 the first commercial test for [[Hepatitis C virus]] (HCV) [[genotyping]] worldwide (INNO-LiPA HCV). In 1995, the first commercial Alzheimer&amp;#039;s disease research test for [[Tau protein|hTau]] was launched (INNOTEST hTau Ag). In 1998, the company launched the first commercial Alzheimer&amp;#039;s disease research test for β-[[Amyloid]] and in 2002 the first commercial test for [[Hepatitis B virus]] (HBV) genotyping (INNO-LiPA HBV Genotyping).&lt;br /&gt;
&lt;br /&gt;
The company was one of the first biotech companies to be listed on a European [[stock exchange]], in 1996 it was the first biotech company listed on EASDAQ, now [[NASDAQ]] Europe. Until 2008 Innogenetics had its shares traded on [[Euronext]] [[Brussels]].&lt;br /&gt;
&lt;br /&gt;
Innogenetics N.V. was acquired by [[Fujirebio]] in 2010 and changed name to Fujirebio Europe N.V. on October 1, 2013.&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*[http://www.fujirebio.com/ Fujirebio website in English]&lt;br /&gt;
*[https://www.hugp.com/en/ H.U. Group website in English]&lt;br /&gt;
&lt;br /&gt;
{{Authority control}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Biotechnology companies of Belgium]]&lt;br /&gt;
[[Category:Pharmaceutical companies of Belgium]]&lt;br /&gt;
[[Category:Companies based in Ghent]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Silverije</name></author>
	</entry>
</feed>